Trials / Unknown
UnknownNCT04246073
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Identification of the Most Relevant Risk Factors for Thromboembolism
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Hellenic Society of Surgical Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non interventional multi-centric study that will aim in evaluating the efficacy and safety of Fondaparinux in surgical cancer patients, identifying in parallel the most relevant and critical risk factors for Thromboembolism.
Detailed description
Non interventional multi-centric study that will aim in evaluating the efficacy and safety of Fondaparinux in surgical cancer patients, identifying in parallel the most relevant and critical risk factors for Thromboembolism. It is a cohort study, recruiting cancer patients over 18 years of age, who have been diagnosed with cancer for over a period of one year. Exclusion criteria apply as well while all patients can withdraw their participation at any time point.
Conditions
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2020-10-01
- Completion
- 2020-12-01
- First posted
- 2020-01-29
- Last updated
- 2020-07-31
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04246073. Inclusion in this directory is not an endorsement.